News

MPR1h
FDA Approves Neuroimmune Modulation Device for Rheumatoid Arthritis
The SetPoint System consists of a neurostimulation device that is surgically placed under general anesthesia on the vagus nerve.
MPR2h
Cardiovascular Benefit Seen With Tirzepatide in Head-to-Head Trial
SURPASS-CVOT evaluated the efficacy and safety of tirzepatide compared with dulaglutide in adults with T2D and a confirmed ASCVD.
MPR4h
Stopping Menopausal Hormone Therapy May Temporarily Increase Fracture Risk
Fracture risk then decreases to levels similar to and then lower than women who have never used menopausal hormone therapy.
MPR4h
Nirsevimab Effective for Protecting Infants From RSV Lower Respiratory Tract Disease
Effectiveness seen for RSV lower respiratory tract disease, hospitalized RSV lower respiratory tract disease, PCR-confirmed RSV.
MPR4h
US Senate Confirms Infection Expert as New CDC Director
On issues such as vaccination and fluoridation of public water supplies, some of Monarez’s comments appeared to be at odds with those of Health and Human Services Secretary Robert F. Kennedy Jr.
MPR23h
CardioTag, a Wearable Cardiac Monitoring Device, Gets FDA Clearance
The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.